Informações: Esta não é a versão mais recente do modelo de dados. Uma visão geral da versão pode ser encontrada à esquerda em Versões. Para a versão mais recente, clique aqui.
Informações:
Falhas:
ID
16454
Descrição
A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00152477
Link
https://clinicaltrials.gov/show/NCT00152477
Palavras-chave
Versões (2)
- 17/07/2016 17/07/2016 -
- 21/07/2016 21/07/2016 - Julian Varghese
Transferido a
17 de julho de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Carcinoma NCT00152477
Eligibility Carcinoma NCT00152477
- StudyEvent: Eligibility
Similar models
Eligibility Carcinoma NCT00152477
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Lung Carcinoma
Item
male and female subjects with stage iiib (with malignant pleural effusion or if no pleural effusion is present subjects who are not candidates for combined modality therapy), stage iv, or recurrent non-squamous, non-small-cell lung carcinoma.
boolean
C0007131 (UMLS CUI [1])
Age
Item
the subject must be aged 18 years or above.
boolean
C0001779 (UMLS CUI [1])
ECOG and life expectancy
Item
the subject must have ecog performance status of 0 or 1 and a life expectancy of at least three months.
boolean
C1520224 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
C0023671 (UMLS CUI [2])
Measurable Disease
Item
subjects will have measurable disease.
boolean
C1513041 (UMLS CUI [1])
Informed Consent
Item
the subject must be able to understand the information provided to them and to give written informed consent.
boolean
C0021430 (UMLS CUI [1])
Childbearing Potential
Item
female subjects must be either postmenopausal, surgically sterilized, or using a method of contraception judged reliable by the investigator.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,2])
Contraception
Item
male subjects must be using a method of contraception judged reliable by the investigator.
boolean
C0700589 (UMLS CUI [1])
Squamous cell lung carcinoma
Item
subjects with squamous cell lung carcinoma.
boolean
C0149782 (UMLS CUI [1])
lung lesions located centrally in the chest
Item
subjects with lung lesions located centrally in the chest that involve major blood vessels.
boolean
C0577916 (UMLS CUI [1,1])
C0929406 (UMLS CUI [1,2])
C0929406 (UMLS CUI [1,2])
Malignancies
Item
concurrent active malignancy other than nonmelanoma skin cancer or carcinoma in situ of the cervix. subjects with previous malignancies are eligible provided that they have been disease free for five years or more.
boolean
C0006826 (UMLS CUI [1])
additional major chronic disease
Item
presence of additional major chronic disease such as hepatic or renal dysfunction, cardiac dysfunction, peripheral vascular disease, evidence of a myocardial infarction within six months of screening visit, tuberculosis or epilepsy.
boolean
C0008679 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
hepatitis b or c virus or hiv 1 or 2
Item
subjects known to be infected with hepatitis b or c virus or hiv 1 or 2.
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0019693 (UMLS CUI [3])
C0019196 (UMLS CUI [2])
C0019693 (UMLS CUI [3])
Infection
Item
any evidence of serious active infection (ie requiring an iv antibiotic or antiviral agent).
boolean
C0009450 (UMLS CUI [1])